Showing results (171-180 of 347) with videos related to

Sort By:
Pageof 35
Journal of Managed Care & Specialty Pharmacy|May 10, 2017
Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart FailureZubaid Rafique, Matthew R Weir, Macaulay Onuigbo, et al.
International Journal of Nephrology and Renovascular Disease|September 2, 2017
Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trialLarry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2002
Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control studyJeffrey C Fink, Macaulay A Onuigbo, Steven A Blahut, et al.
Transplantation Direct|November 15, 2019
Blood Pressure and Living Kidney Donors: A Clinical PerspectiveAnjay Rastogi, Stanley Yuan, Farid Arman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
The Effects of Candesartan Cilexetil in Isolated Systolic Hypertension: A Clinical Experience TrialJoel M. Neutel, Matthew R. Weir, Marvin Moser, et al.
Journal of Hypertension|January 28, 2017
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diureticsMatthew R Weir, Martha R Mayo, Dahlia Garza, et al.
Coronary Artery Disease|December 24, 2005
The metabolic syndrome: a call to actionAntonio M Gotto, George L Blackburn, George E Dailey, et al.
The American Journal of Medicine|September 26, 2017
Infection and Malignancy Outweigh Cardiovascular Mortality in Kidney Transplant Recipients: Post Hoc Analysis of the FAVORIT TrialLarry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
Pageof 35